Sound Income Strategies’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EPGL
RG
N
Sound Income Strategies's AZN Position: Q2 2026 in Review
Sound Income Strategies sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 788 shares — an estimated $158K sold.
Sound Income Strategies first reported a position in AZN in Q2 2018 and held it in 23 quarters. The position peaked at $158K in Q1 2026. 1,087 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Sound Income Strategies reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
- Sound Income Strategies sold 788 AstraZeneca shares in Q2 2026, an estimated $158K.
- Sound Income Strategies first reported a position in AstraZeneca in Q2 2018 and held it in 23 quarters.
- Sound Income Strategies's AstraZeneca position peaked at $158K in Q1 2026.
- 1,087 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.